United States · Exchanges & live quotes · Nasdaq
Cocrystal Pharma Posts Wider Q3 Loss, Led By Norovirus Challenge Study Costs
Detailed summary
(RTTNews) - Cocrystal Pharma, Inc. (COCP), a clinical stage biotechnology firm, on Sunday reported a wider loss in its third quarter, driven by higher clinical trial and related…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)


